A comprehensive review of advanced strategies to combat antimicrobial resistance

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Antimicrobial resistance (AMR) is a critical global health challenge due to antibiotic overuse and misuse.
• Conventional antimicrobial therapies are increasingly ineffective, with no new antibiotic classes developed in a decade.
• Drug-resistant pathogens necessitate the exploration of novel therapeutic strategies.

Purpose of the Study:

• To review innovative approaches for combating antimicrobial resistance.
• To highlight cutting-edge technologies shifting the paradigm from traditional antibiotics to next-generation therapeutics.
• To emphasize the need for collaborative action to address the AMR crisis.

Main Methods:

• Literature review of novel antimicrobial strategies.
• Analysis of emerging technologies such as antimicrobial peptides, phage therapy, CRISPR-Cas gene editing, and nanomaterial-based antimicrobials.
• Examination of immunomodulatory agents, physicochemical strategies, and combination therapies.

Main Results:

• Several innovative approaches show promise in counteracting AMR.
• These include antimicrobial peptides, phage therapy, CRISPR-Cas gene editing, nanomaterial-based antimicrobials, immunomodulatory agents, and combination therapies.
• These cutting-edge technologies represent a move towards integrated, next-generation therapeutics.

Conclusions:

• Despite advancements, AMR remains a significant threat requiring urgent, multidisciplinary action.
• Inventiveness, cooperation, and proactive strategies are essential to tackle AMR.
• Collaboration among researchers, healthcare professionals, policymakers, and the pharmaceutical sector is crucial.